BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1148383)

  • 21. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cellular immunodeficiency in superficial mycoses and cutaneous viroses].
    Honeyman J; Saavedra T; Villagra R; Cabezas AM; Awad P
    Med Cutan Ibero Lat Am; 1981; 9(3):179-82. PubMed ID: 7026933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunologic reactivity of breast cancer patients].
    Semiglazov VF; Kondrat'ev VB; Mar'enko AI; L'vovich EG; Sofronov BN
    Vopr Onkol; 1978; 24(8):74-9. PubMed ID: 695430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy.
    Van Epps DE; Palmer DL; Williams RC
    J Immunol; 1974 Jul; 113(1):189-200. PubMed ID: 4832308
    [No Abstract]   [Full Text] [Related]  

  • 26. Delayed skin reactivity of patients with herpetic stromal keratitis.
    Ohno S; Kato F; Matsuda H; Hosokawa M; Kobayashi H
    Ann Ophthalmol; 1981 Apr; 13(4):483-5. PubMed ID: 7247195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed hypersensitivity in untreated patients with Hodgkin's disease--with special reference to small lymphocyte counts in the blood.
    Tanaka M
    Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):61-72. PubMed ID: 989232
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immunity in lobomycosis (keloidal blastomycosis).
    Pecher SA; Fuchs J
    Allergol Immunopathol (Madr); 1988; 16(6):413-5. PubMed ID: 3242380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease.
    De Gast GC; Halie MR
    Neth J Med; 1976; 19(4-5):196-200. PubMed ID: 980187
    [No Abstract]   [Full Text] [Related]  

  • 31. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 32. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunodepression after major surgery in normal patients.
    Slade MS; Simmons RL; Yunis E; Greenberg LJ
    Surgery; 1975 Sep; 78(3):363-72. PubMed ID: 1098195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 37. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cellular immunity in the aged as evaluated by a delayed hypersensitivity test in vivo (intradermal test and contact test)].
    DifeliceAntonio R; Sarti G; Savorani G
    Boll Soc Ital Biol Sper; 1976 Jun; 52(12):866-71. PubMed ID: 1023898
    [No Abstract]   [Full Text] [Related]  

  • 39. [Research on cellular immunity in acute leukemia in childhood. Significance of skin tests].
    Pietrogrande MC; Mieli G; Corona F; Ferraris G; Bardare M
    Minerva Pediatr; 1976 Nov; 28(37):2259-64. PubMed ID: 1069900
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic Chagas' disease: unimpaired delayed type hypersensitivity reactions in contrast with humoral suppression to typhoid vaccine.
    Corsini AC; Vilela MM; Piedrabuena AE
    Tropenmed Parasitol; 1981 Jun; 32(2):82-6. PubMed ID: 6789511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.